Internal Medicine, Hematology & Oncology · Baltimore, MD
NPI
1336199942
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5233 King Ave Ste 308
Baltimore, MD, 21237
Phone (410) 780-4050
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
129,037 services
Medicare patients, 2024
546
Average age 74
Drug cost, 2024
$1.7M
365 prescriptions
Company payments, 2025
$1,167
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Auerbach was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 56,455 times for 56 patients. In total Michael Auerbach billed 129,037 services in 89 codes, and Medicare paid $1.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-23.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 56,455 | 56 | $2.31 | $131K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 25,900 | 195 | $15.60 | $404K |
| 36415 Venipuncture Blood Collection | Office | 1,405 | 493 | $8.59 | $12K |
| 85025 Blood Count | Office | 1,199 | 442 | $7.56 | $9,064 |
| J1750 Injection, iron dextran, 50 mg | Office | 1,128 | 49 | $13.47 | $15K |
| 99214 Office E&M - Established | Office | 748 | 322 | $97.10 | $73K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 403 | 22 | $0.23 | $92 |
| 96365 Intravenous Infusion, Hydration | Office | 376 | 275 | $48.90 | $18K |
| 96372 Injection Administration | Office | 327 | 95 | $11.15 | $3,647 |
| 99213 Office E&M - Established | Office | 311 | 235 | $68.68 | $21K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 258 | 49 | $4.65 | $1,200 |
| 96413 Chemotherapy Administration | Office | 160 | 30 | $102.44 | $16K |
| 96375 Injection Administration | Office | 115 | 46 | $12.54 | $1,442 |
| 96367 Intravenous Infusion, Hydration | Office | 101 | 41 | $22.78 | $2,300 |
| 99204 Office E&M - New | Office | 101 | 101 | $121.11 | $12K |
By year: 2022 $2.5M for 181,445 services; 2023 $2.5M for 205,145 services; 2024 $1.8M for 129,037 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,405 | 493 | $8.59 | $12K |
| 85025 Blood Count | 1,199 | 442 | $7.56 | $9,064 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael Auerbach prescribed most often to Medicare patients was Hydroxyurea, with 59 prescriptions and refills. In total Michael Auerbach wrote 365 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 59 | 149 | 18 | $2,247 |
| Acyclovir Generic | 42 | 126 | 14 | $665 |
| Anastrozole Generic | 25 | 75 | Under 11 | $642 |
| Lenalidomide Generic | 23 | 23 | Under 11 | $286K |
| Chlorhexidine Gluconate Generic | 21 | 23 | Under 11 | $82.63 |
| Xarelto Rivaroxaban | 18 | 28 | Under 11 | $15K |
| Revlimid Lenalidomide | 15 | 15 | Under 11 | $277K |
| Pomalyst Pomalidomide | 13 | 13 | Under 11 | $298K |
| Sprycel Dasatinib | 12 | 12 | Under 11 | $141K |
| Pyrukynd Mitapivat Sulfate | 12 | 12 | Under 11 | $307K |
| Exemestane Generic | 11 | 33 | Under 11 | $2,526 |
Brand drugs: 106 claims; generic drugs: 259 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Auerbach $1,167 ($1,167 in general payments such as food, travel and fees) from 24 companies. The largest payer was Novartis Pharmaceuticals Corporation with $186.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 9 | $186 |
| Pfizer Inc. PFE | 5 | $110 |
| Janssen Biotech, Inc. JNJ | 3 | $90.26 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $70.03 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $65.83 |
| Abbvie Inc. ABBV | 3 | $63.63 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $62.21 |
| GlaxoSmithKline, LLC. GSK | 3 | $54.78 |
| Celgene Corporation BMY | 2 | $51.56 |
| Daiichi Sankyo Inc. 4568.T | 2 | $48.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.